Sixfold Bio raises €2.0M Seed round
2 December 2021· London, United Kingdom· health, biotechnology, nanotechnology, ai, software_hardware, b2b
To support the continued development and expansion of the Company's Mergo® RNA therapeutics delivery platform across several therapeutic indications.
Investors
LeadCantos Ventures
Also participating
Y Combinatorangel investorsLombardstreet VenturesPi Campus
About Sixfold Bio
Stage
Seed
Headquarters
London, United Kingdom
Founded
2017
Team Size
21–50
Sectors
healthbiotechnologynanotechnologyaisoftware_hardwareb2b